Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3′-Kinase Pathway*
Author:
Affiliation:
1. The Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia V6H 3Z6; and Division of Urology, University of British Columbia, Vancouver, British Columbia V5Z 3J5, Canada
Publisher
The Endocrine Society
Subject
Endocrinology
Link
http://academic.oup.com/endo/article-pdf/141/6/2257/10363695/endo2257.pdf
Reference44 articles.
1. Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer.;Denis;Cancer,1993
2. Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.;Isaacs;Cancer Res,1982
3. The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer.;Issacs;Prostate,1984
4. Target to apoptosis: a hopeful weapon for prostate cancer.;Tang;Prostate,1997
5. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.;Taplin;N Engl J Med,1995
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones;Nature Communications;2022-09-17
2. Regulation of AR mRNA translation in response to acute AR pathway inhibition;Nucleic Acids Research;2021-12-23
3. The role of insulin-like growth factors in the development of prostate cancer;Expert Review of Endocrinology & Metabolism;2020-05-22
4. Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease;Frontiers in Endocrinology;2020-03-03
5. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma;Scientific Reports;2020-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3